Hepatitis Elimination Series at the World Health Assembly 2021

On the margin of the 2021 World Health Assembly, The Hepatitis Fund and the World Economic Forum, in collaboration with WHO, held a one-hour live online event focused on financing the elimination of viral hepatitis as a public health threat.

Almost 300 participants from civil society, governments, international organisations, philanthropy and industry as well as selected global leaders joined during this session to share their understanding of different funding streams, investment models and how catalytic funding could be leveraged to increase coverage for hepatitis elimination.

Watch the WHA side-event here 


We are the only grant-making organization dedicated exclusively to the mission of ending viral hepatitis.

By funding a variety of the most effective activities, EndHep2030 intends to overcome the barriers that prevent countries from properly addressing viral hepatitis — a pandemic that will kill 1.4 million people this year — as a global public health threat.





Highly Motivated

More than 10% of Mongolia’s three million people are living with chronic hepatitis infection. The chances of a mother with viral hepatitis giving birth to an infected baby who develops life-long infection can be as high as 85%.

Fortunately, though heavily burdened by the disease, Mongolia has become a champion in the fight against it. In the first year of its Healthy Liver Program, more than 350,000 people were tested, and over 70% of those diagnosed with hepatitis were provided with treatment that is life-saving and prevents infection to others.

The means to prevent and cure the disease exist now. All we need is the will — and commitment — to make it happen.